Dr. Jessica Minion MD, MSc, FRCPC, D(ABMM)
Assistant Professor Pathology and Laboratory Medicine

Dr. Minion holds academic degrees from the University of Alberta, University of Calgary, and McGill University in the fields of science, medicine, and epidemiology. She is a fellow of the Royal College of Physicians and Surgeons of Canada, specialized in Medical Microbiology. Since 2012, Dr. Minion has served as the Division Head of Microbiology & Infection Prevention and Control in Regina, Saskatchewan. In 2017 she accepted the role of Acting Medical Director of the Roy Romanow Provincial Laboratory, which has transitioned into the Provincial Clinical Lead of Public Health, in the Department of Laboratory Medicine of the amalgamated Saskatchewan Health Authority. In this capacity, she oversees laboratory testing for diseases and organisms of public health interest in Saskatchewan, holds responsibility for the laboratory response to issues of public health concern, and coordinates with both provincial and national organizations to enhance and promote the impact of public health laboratory activities and services.

CHAPTERS IN BOOKS

• Pai M, Minion J, Jamieson F, Wolfe J, Behr M. (2013). Diagnosis of active tuberculosis and drug resistance. In Menzies, D (Ed.) Canadian Tuberculosis Standards, 7^th Edition (pp. 43 – 63). Ottawa: Canadian Thoracic Society, Canadian Lung Association, and the Public Health Agency of Canada.

PAPERS IN REFEREED JOURNALS

• Tsybina P, Hennink M, Diener T, Minion J, Lang A, Lavoie S, Kim J, Wong A. (2020). Repeated false reactive ADVIA Centaur® and Bio-Rad Geenius™ HIV tests in a patient self-administering anabolic steroids. BMC Infectious Disease. 20(1):9
• Demczuk W, Martin I, Sawatzky P, Allen V, Lefebvre B, Hoang L, Naidu P, Minion J, VanCaeseele P, Haldane D, Eyre DW, Mulvey MR. (2020). Equations to predict antimicrobial MICs in Neisseria gonorrhoeae using molecular antimicrobial resistance determinants. Antimicrobial Agents and Chemotherapy. 64(3):e02005-19
• Tsang RSW, Shuel M, Ahmad T, Hayden K, Knox N, Van Domselaar G, Hoang L, Tyrrell GJ, Minion J, Van Caeseele P, Kus JV, Ulanova M, Lefebvre B, Haldane D, Garceau R, German G, Zahariadis G, Hanley B, Kandola K, Patterson M. (2020). Whole genome sequencing to study the phylogenetic structure of serotype a Haemophilus influenza recovered from patients in Canada. Canadian Journal of Microbiology. 66(2):99-110
• Parmar NR, Perera SR, Wang J, Levett PN, Minion J, Dillon JR. (2019). Characterization of antimicrobial resistance genes from Neisseria gonorrhoeae positive remnant Aptima urine specimens. Future Microbiology. 14:1559-1571.
• Tsang RS, Hoang L, Tyrrell GJ, Minion J, Van Caeseele P, Kus JV, Lifebvre B, Haldane D, Garceau R, German G, Zahariadis G, Hanley B. (2019). Increase in ST-11 serogroup W Neisseria meningitides invasive meningococcal disease in Canada, 2016-2018. Canadian Communicable Disease Report. 45(6):164-169
• Agopsowicz CA, Bailey P, Barth C, Hicock AQ, Minion J. (2019). An evaluation of HPC for Quanti-Tray with membrane filtration method for hemodialysis water analysis. Journal of Hospital Infection (submitted)
• Martin I, Sawatzky P, Allen V, Lefebvre B, Hoang LMN, Naidu P, Minion J, Van Caeseele P, Haldane D, Gad RR, Zahariadis G, Corriveau A, German G, Thomas K, Mulvey MR. (2019). Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012-2016. Canadian Communicable Disease Report. 45:45-53
• Golden AR, Adam HJ, Baxter M, Nichol KA, Martin I, Demczuk W, Van Caeseele P, Gubbay JB, Lefebvre B, Minion J, Zahariadis G, Haldane D, Gad R, German G, Mulvey MR, Karlowsky JR, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). (2019). The impact of recombination and mutation on the development of MDR in Streptococcus pneumoniae in Canada. Emerging Infectious Diseases Journal. (submitted)
• Katz KC, Golding GR, Choi KB, Prelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans G, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N, for the Canadian Nosocomial Infection Surveillance Program. (2018). The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015). Canadian Medical Association Journal. 190: E758-65
• Lang R, Minion J, Skinner S, Wong A. (2018). Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis. BMC Infectious Diseases 18:255
• Lorenz S, Minion J, Mamata P, Karunakaran K. (2018). Blastomycosis in Southern Saskatchewan 2000-2015: Unique presentations and disease characteristics. Medical Mycology 56(1): 787-795
• German GJ, Gilmour M, Tipples G, Adam HJ, Almohri H, Bullard J, Dingle T, Farrell D, Girouard G, Haldane D, Hoang L, Levett PN, Melano R, Minion J, Needle R, Patel SN, Rennie R, Reyes RC, Longtin J, Mulvey MR. (2018). Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, Actinobacter species and Pseudomonas aeruginosa. Canadian Communicable Disease Report, 44(1):29-34.
• Shahina Z, El-Ganiny A, Minion J, Whiteway M, Sultana T, Dahms T. (2018). Cinnamomum zeylanicum bark essential oil induces cell wall remodelling and spindle defects in Candida albicans. Fungal Biology and Biotechnology, 5:3.
• Lang R, Minion J, Wong A. (2017). Hematospermia in a returned traveler. Canadian Urologic Association Journal, 11(1):E41-43.
• Horne DJ, Pinto LM, Arentz M, Lin SY, Desmond E, Flores LL, Steingart KR, Minion J. (2013). Diagnostic accuracy and reproducibility of WHO-endorsed phenotypic drug susceptibility testing methods for first-line and second-line antituberculosis drugs. Journal of Clinical Microbiology. 51(2): 393-401.
• Minion J, Gallant V, Wolfe J, Jamieson F, Long R. (2013). Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics. PLoS ONE. 8(1):e53466.
• Khan FA, Minion J, Al-Motairi A, Benedetti A, Harries AD, Menzies D. (2013) An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection Clinical Infectious Diseases. 55(8): 1154-63.
• Denkinger C, Grenier J, Minion J, Pai M. (2012). Promise versus reality: a comparison of test accuracy claims in package inserts of tuberculosis diagnostics versus meta-analyses estimates Journal of Clinical Microbiology. 50(7): 2455-2461.
• Chartrand C, Leeflang M, Minion J, Brewer T, Pai M. (2012). Accuracy of rapid influenza diagnostic tests: a meta-analysis. Annals of Internal Medicine. 156:500-511
• Leung E, Minion J, Benedetti A, Pai M, Menzies D. (2012). Microcolony culture techniques for tuberculosis diagnosis: a systematic review. International Journal of Tuberculosis and Lung Disease. 16(1):16-23.
• Flores LL, Steingart KR, Dendukuri N, Schiller I, Minion J, Pai M, Ramsay A, Henry M, Laal S. (2011). Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis. Clinical and Vaccine Immunology. 18(10): 1616-27.
• Minion J, Pai M, Ramsay A, Menzies D, Greenaway C. (2011). Comparison of LED and conventional fluorescence microscopy for detection of acid-fast bacilli in a low-incidence setting. PLoS ONE. 6(7):e22495.
• Minion J, Leung E, Talbot E, Kheertan D, Pai M, Menzies D. (2011). Urinary lipoarabinomannan (LAM) antigen detection for the diagnosis of tuberculosis: a systematic review and meta-analysis. European Respiratory Journal. 38(6):1398-1405.
• Minion J, Shenai S, Vadwai V, Tipnis T, Greenaway C, Menzies D, Ramsay A, Rodrigues C, Pai M. (2011). Fading of auramine-stained mycobacterial smears and implications for external quality assurance. Journal of Clinical Microbiology. 9(5):2024-2026.
• Shenai S, Minion J, Vadwai V, Tipnis T, Shetty S, Salvi A, Udwadia Z, Pai M, Rodrigues C. (2011). Evaluation of LED based fluorescent microscopy for the detection of mycobacteria in a TB endemic region. International Journal of Tuberculosis and Lung Disease. 15(4):483-488.
• Minion J, Pai M. (2011). Assays for drug resistant tuberculosis in high burden countries – authors’ reply. Lancet Infectious Diseases. 3(11):162.
• Chartrand C, Minion J, Pai M. (2010). Rapid diagnostics for influenza: what is on the market? Future Microbiology. 5:1451-5.
• Minion J, Leung E, Menzies D, Pai M. (2010). Microscopic-Observation Drug Susceptibility (MODS) and Thin Layer Agar (TLA) assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infectious Diseases. 10:688-98.
• Minion J, Pai M. (2010). Bacteriophage assays for rifampin resistance detection in Mycobacterium tuberculosis: updated meta-analysis. International Journal of Tuberculosis and Lung Disease. 14(8): 941-51.
• Pai M, Minion J, Steingart K, Ramsay A. (2010). New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Current Opinions in Pulmonary Medicine. 16(3):271-84.
• Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, Menzies D. (2010). Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clinical Infectious Diseases. 50(9):1288-99.
• Minion J, Pai M. (2010). Expanding the role of the microscopic observation drug susceptibility assay in tuberculosis and HIV management. Clinical Infectious Diseases. 50(7):997-9.
• Minion J, Pai M. (2010). Evidence-based diagnosis of tuberculosis: resources for the medical microbiologist. Indian Journal of Medical Microbiology. 28(1):2-4.
• Pai M, Minion J, Sohn H, Zwerling A, Perkins MD. (2009). Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clinics in Chest Medicine. 30(4):701-16.
• Minion J, Sohn H, Pai M. (2009). Light-emitting diode technologies for TB diagnostics: what is on the market? Expert Review of Medical Devices. 6(4):341-5.
• Sohn H, Minion J, Albert H, Dheda K, Pai M. (2009). TB diagnostic tests: how do we figure out their costs? Expert Rev Anti Infect. 7(6):723-33.
• Minion J, Zwerling A, Pai M. (2009). Diagnostics for tuberculosis: what new knowledge did we gain through The International Journal of Tuberculosis and Lung Disease in 2008? Int J Tuberc Lung Dis. 13(6):691-7.
• Tyrrell GJ, Lovgren M, Chui N, Minion J, Garg S, Kellner JD, Marrie TJ. (2009). Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post- seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006. Vaccine. 27(27): 3553-60.
• Kaufman WR, Minion JL. (2006). Pharmacologic characterization of the ergot alkaloid receptor in the salivary gland of the ixodid tick Amblyomma hebraeum. Journal of Experimental Biology. 209(13):2525-34.